المؤلفون: Ji Zeng, Shuying Fang, Jinquan Guo, Min Dong, Guo‐Bao Tian, Liang Tao

المصدر: mLife, Vol 3, Iss 1, Pp 14-20 (2024)

مصطلحات موضوعية: C. difficile, sporulation, TcdA, TcdB, toxin production, Microbiology, QR1-502

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2770-100XTest

الوصول الحر: https://doaj.org/article/7f53f63db154472b872602f6d7c2c646Test

المؤلفون: D. Annie Doyle, Paul L. DeAngelis, Jimmy D. Ballard

المصدر: mSphere, Vol 9, Iss 4 (2024)

مصطلحات موضوعية: Clostridioides difficile, TcdB, calcium, chondroitin sulfate, Microbiology, QR1-502

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2379-5042Test

الوصول الحر: https://doaj.org/article/d83cc968d45749fc9dbdd1fefe040b08Test

المؤلفون: Ashleigh S. Paparella, Isabella Brew, Huynh A. Hong, William Ferriera, Simon Cutting, Farah Lamiable-Oulaidi, Michael Popadynec, Peter C. Tyler, Vern L. Schramm

مصطلحات موضوعية: Biochemistry, Microbiology, Cell Biology, Ecology, Immunology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, two murine models, glucocation transition state, multiple toxin variants, length toxin variants, important therapeutic targets, induced cell rounding, tcdb use udp, preventing recurring c, multiple tcdb variants, isofagomine inhibits tcda, sequence variants, isofagomine inhibits, important barrier, induced morbidity, tcdb across, protects tcdb, isofagomine treatment, isofagomine supports, isofagomine protects, isofagomine inhibition, threatening diarrhea

العلاقة: https://figshare.com/articles/journal_contribution/Isofagomine_Inhibits_Multiple_TcdB_Variants_and_Protects_Mice_from_Clostridioides_difficile-Induced_Mortality/25196713Test

الإتاحة: https://doi.org/10.1021/acsinfecdis.3c00507.s001Test
https://figshare.com/articles/journal_contribution/Isofagomine_Inhibits_Multiple_TcdB_Variants_and_Protects_Mice_from_Clostridioides_difficile-Induced_Mortality/25196713Test

المؤلفون: Md Zahidul Alam, Rajat Madan

المصدر: Toxins, Vol 16, Iss 6, p 241 (2024)

مصطلحات موضوعية: Clostridioides difficile infection, C. difficile transferase (CDT), toxin A (TcdA) and toxin B (TcdB), GTPase proteins, pathogenicity locus (PaLoc), Medicine

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6651/16/6/241Test; https://doaj.org/toc/2072-6651Test

الوصول الحر: https://doaj.org/article/816e6b2cc85d4cb99b1e640e35d8bd09Test

المؤلفون: Aditi Dubey, Madison Baxter, Kevin J. Hendargo, Arturo Medrano-Soto, Milton H. Saier

المصدر: International Journal of Molecular Sciences, Vol 25, Iss 9, p 5005 (2024)

مصطلحات موضوعية: VIC superfamily, pLIC family, TCDB, homology, bioinformatics, Biology (General), QH301-705.5, Chemistry, QD1-999

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1422-0067/25/9/5005Test; https://doaj.org/toc/1661-6596Test; https://doaj.org/toc/1422-0067Test

الوصول الحر: https://doaj.org/article/f6a9a2b887274f70ae1ee747e9fdb837Test

المؤلفون: Yuhang Shen, Shan Lin, Peijun You, Yu Chen, Yun Luo, Xiaojun Song, Yunbo Chen, Dazhi Jin

المصدر: Frontiers in Microbiology, Vol 15 (2024)

مصطلحات موضوعية: Clostridioides difficile, infection, colonization, real-time cell analysis, TcdB, Microbiology, QR1-502

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fmicb.2024.1348892/fullTest; https://doaj.org/toc/1664-302XTest

الوصول الحر: https://doaj.org/article/91af9760108144ff99c1ab4d6436ff0bTest

المؤلفون: Aminzadeh, Aria, Hilgers, Luuk, Paul Platenburg, Peter, Riou, Mickaël, Perrot, Noémie, Rossignol, Christelle, Cauty, Axel, Barc, Céline, Jørgensen, René

المصدر: Aminzadeh , A , Hilgers , L , Paul Platenburg , P , Riou , M , Perrot , N , Rossignol , C , Cauty , A , Barc , C & Jørgensen , R 2024 , ' Immunogenicity and safety in rabbits of a Clostridioides difficile vaccine combining novel toxoids and a novel adjuvant ' , Vaccine , vol. 42 , no. 7 , pp. 1582-1592 . https://doi.org/10.1016/j.vaccine.2024.01.076Test

مصطلحات موضوعية: Alum, Carbohydrate fatty acid monosulphate esters, CDI, Clostridioides difficile, Clostridium difficile, CMS, CMS adjuvant, Rabbits, TcdA, TcdB, Toxins, Vaccine

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016/j.vaccine.2024.01.076Test
https://forskning.ruc.dk/da/publications/15579d70-71b1-455f-8ea0-83c6c01ab9afTest
https://hdl.handle.net/1800/15579d70-71b1-455f-8ea0-83c6c01ab9afTest
https://rucforsk.ruc.dk/ws/files/100468173/1-s2.0-S0264410X24001014-main.pdfTest

المؤلفون: K. E. Popruga, V. V. Makarov, К. Э. Попруга, В. В. Макаров

المصدر: Journal Infectology; Том 15, № 4 (2023); 35-41 ; Журнал инфектологии; Том 15, № 4 (2023); 35-41 ; 2072-6732 ; 10.22625/2072-6732-2023-15-4

مصطلحات موضوعية: наноантитела, TcdA, TcdB, immunotherapy, monoclonal antibodies, bezlotoxumab, nanobodies, иммунотерапия, моноклональные антитела, безлотоксумаб

وصف الملف: application/pdf

العلاقة: https://journal.niidi.ru/jofin/article/view/1565/1096Test; Buddle J.E., Fagan R.P. Pathogenicity and virulence of Clostridioides difficile // Virulence. 2023. Vol. 14, № 1.; Hota S.S. et al. Determining Mortality Rates Attributable to Clostridium difficile Infection // Emerg. Infect. Dis. 2012. Vol. 18, № 2. P. 305–307.; Czepiel J. et al. Clostridium difficile infection: review // Eur. J. Clin. Microbiol. Infect. Dis. 2019. Vol. 38, № 7. P. 1211–1221.; Dobson G., Hickey C., Trinder J. Clostridium difficile colitis causing toxic megacolon, severe sepsis and multiple organ dysfunction syndrome // Intensive Care Med. 2003. Vol. 29, № 6. P. 1030–1030.; Guery B. Clostridium difficile infection trials: what is the primary endpoint? // Lancet Infect. Dis. 2019. Vol. 19, № 3. P. 219–220.; Bartlett J.G. Narrative Review: The New Epidemic of Clostridium difficile –Associated Enteric Disease // Ann. Intern. Med. 2006. Vol. 145, № 10. P. 758.; Marra A.R. et al. Incidence and Outcomes Associated With Clostridium difficile Infections // JAMA Netw. Open. 2020. Vol. 3, № 1. P. e1917597.; Hall A.J. et al. The Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999–2007 // Clin. Infect. Dis. 2012. Vol. 55, № 2. P. 216–223.; Dubberke E.R., Olsen M.A. Burden of Clostridium difficile on the Healthcare System // Clin. Infect. Dis. 2012. Vol. 55, № suppl_2. P. S88–S92.; Филь Т.С. Стратификация факторов риска развития антибиотикоассоциированной диареи: автореф. дис. . канд. наук 2017.; Nikolaeva I. V. et al. Clostridioides (Clostridium) difficile infection. Review of current clinical guidelines // Pract. Med. 2020. Vol. 18, № 6. P. 106–112.; Hensgens M.P.M. et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics // J. Antimicrob. Chemother. 2012. Vol. 67, № 3. P. 742–748.; Theriot C.M., Young V.B. Interactions Between the Gastrointestinal Microbiome and Clostridium difficile // Annu. Rev. Microbiol. 2015. Vol. 69, № 1. P. 445–461.; Theriot C.M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection // Nat. Commun. 2014. Vol. 5, № 1. P. 3114.; Owens, Jr. R.C. et al. Antimicrobial-Associated Risk Factors for Clostridium difficile Infection // Clin. Infect. Dis. 2008. Vol. 46, № s1. P. S19–S31.; Surawicz C.M. et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections // Am. J. Gastroenterol. 2013. Vol. 108, № 4. P. 478–498.; Debast S.B., Bauer M.P., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection // Clin. Microbiol. Infect. 2014. Vol. 20. P. 1–26.; McFarland L. V. et al. Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics // Infect. Control Hosp. Epidemiol. 1999. Vol. 20, № 01. P. 43–50.; Ghantoji S.S. et al. Economic healthcare costs of Clostridium difficile infection: a systematic review // J. Hosp. Infect. 2010. Vol. 74, № 4. P. 309–318.; Kuehne S.A. et al. The role of toxin A and toxin B in Clostridium difficile infection // Nature. 2010. Vol. 467, № 7316. P. 711–713.; Aktories K. Bacterial protein toxins that modify host regulatory GTPases // Nat. Rev. Microbiol. 2011. Vol. 9, № 7. P. 487–498.; Pruitt R.N. et al. Structural organization of the functional domains of Clostridium difficile toxins A and B // Proc. Natl. Acad. Sci. 2010. Vol. 107, № 30. P. 13467–13472.; Kordus S.L., Thomas A.K., Lacy D.B. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics // Nat. Rev. Microbiol. 2022. Vol. 20, № 5. P. 285–298.; Chen P. et al. Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection // Nat. Commun. 2021. Vol. 12, № 1. P. 3748.; Kyne L. et al. Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A // N. Engl. J. Med. 2000. Vol. 342, № 6. P. 390–397.; Kyne L. et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea // Lancet. 2001. Vol. 357, № 9251. P. 189–193.; Leav B.A. et al. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI) // Vaccine. 2010. Vol. 28, № 4. P. 965–969.; Raeisi H. et al. Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective // Front. Immunol. 2022. Vol. 13.; Wilcox M.H. et al. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection // N. Engl. J. Med. 2017. Vol. 376, № 4. P. 305–317.; Rupnik M. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes // FEMS Microbiol. Rev. 2008. Vol. 32, № 3. P. 541–555.; Shen E. et al. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B // Commun. Biol. 2020. Vol. 3, № 1. P. 347.; Hernandez L.D. et al. Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted by In Vitro Neutralization and Epitope Modeling // Antimicrob. Agents Chemother. 2015. Vol. 59, № 2. P. 1052–1060.; Orrell K.E., Melnyk R.A. Large Clostridial Toxins: Mechanisms and Roles in Disease // Microbiol. Mol. Biol. Rev. 2021. Vol. 85, № 3.; Lyras D. et al. Toxin B is essential for virulence of Clostridium difficile // Nature. 2009. Vol. 458, № 7242. P. 1176–1179.; Drudy D., Fanning S., Kyne L. Toxin A-negative, toxin B-positive Clostridium difficile // Int. J. Infect. Dis. 2007. Vol. 11, № 1. P. 5–10.; Lyerly D.M. et al. Effects of Clostridium difficile toxins given intragastrically to animals // Infect. Immun. 1985. Vol. 47, № 2. P. 349–352.; Lee Y. et al. Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection. // P T. 2017. Vol. 42, № 12. P. 735–738.; Muyldermans S. Nanobodies: Natural Single-Domain Antibodies // Annu. Rev. Biochem. 2013. Vol. 82, № 1. P. 775–797.; Koide A. et al. Exploring the Capacity of Minimalist Protein Interfaces: Interface Energetics and Affinity Maturation to Picomolar KD of a Single-domain Antibody with a Flat Paratope // J. Mol. Biol. 2007. Vol. 373, № 4. P. 941–953.; Jovčevska I., Muyldermans S. The Therapeutic Potential of Nanobodies // BioDrugs. 2020. Vol. 34, № 1. P. 11–26.; Arbabi-Ghahroudi M., Tanha J., MacKenzie R. Isolation of Monoclonal Antibody Fragments from Phage Display Libraries. 2009. P. 341–364.; De Vos J. et al. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target // Expert Opin. Biol. Ther. 2013. Vol. 13, № 8. P. 1149–1160.; Arbabi-Ghahroudi M., Tanha J., MacKenzie R. Prokaryotic expression of antibodies // Cancer Metastasis Rev. 2005. Vol. 24, № 4. P. 501–519.; Dmitriev O.Y., Lutsenko S., Muyldermans S. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells // J. Biol. Chem. 2016. Vol. 291, № 8. P. 3767–3775.; Ackaert C. et al. Immunogenicity Risk Profile of Nanobodies // Front. Immunol. 2021. Vol. 12.; Unger M. et al. Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT // Sci. Rep. 2015. Vol. 5, № 1. P. 7850.; Greco A. et al. Carbohydrate recognition by Clostridium difficile toxin A // Nat. Struct. Mol. Biol. 2006. Vol. 13, № 5. P. 460–461.; Hussack G. et al. Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain // J. Biol. Chem. 2011. Vol. 286, № 11. P. 8961–8976.; Murase T. et al. Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile // J. Biol. Chem. 2014. Vol. 289, № 4. P. 2331–2343.; Yang Z. et al. A Novel Multivalent, Single-Domain Antibody Targeting TcdA and TcdB Prevents Fulminant Clostridium difficile Infection in Mice // J. Infect. Dis. 2014. Vol. 210, № 6. P. 964–972.; https://journal.niidi.ru/jofin/article/view/1565Test

الإتاحة: https://doi.org/10.22625/2072-6732-2023-15-4-35-41Test
https://doi.org/10.22625/2072-6732-2023-15-4Test
https://journal.niidi.ru/jofin/article/view/1565Test

المؤلفون: Diane Sapa, Anaïs Brosse, Héloïse Coullon, Gauthier Péan de Ponfilly, Thomas Candela, Alban Le Monnier

المصدر: Toxins, Vol 16, Iss 1, p 38 (2024)

مصطلحات موضوعية: Clostridioides difficile, toxin, recombinant protein, cytotoxic activity, TcdA, TcdB, Medicine

العلاقة: https://www.mdpi.com/2072-6651/16/1/38Test; https://doaj.org/toc/2072-6651Test; https://doaj.org/article/3f1bd010598a43268634dfcc1d0e47a9Test

الإتاحة: https://doi.org/10.3390/toxins16010038Test
https://doaj.org/article/3f1bd010598a43268634dfcc1d0e47a9Test

المؤلفون: Chen, Baohua, Perry, Kay, Jin, Rongsheng

مصطلحات موضوعية: Medical Microbiology, Biomedical and Clinical Sciences, Digestive Diseases, Infectious Diseases, Prevention, Immunization, Vaccine Related, Emerging Infectious Diseases, Infection, Animals, Bacterial Toxins, Clostridioides difficile, Single-Domain Antibodies, Epitopes, C, difficile infection, TcdA, TcdB, large clostridial glucosylating toxin, VHH, antibody, antitoxin, C. difficile infection, Immunology, Biochemistry and cell biology, Genetics

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6st547wgTest